Prevalence of prostate cancer in the Seventh Region of Chile

被引:0
作者
Baechler, R [1 ]
Henríquez, R [1 ]
Aqueveque, X [1 ]
Martínez, ME [1 ]
Soto, A [1 ]
机构
[1] Hosp Reg Talca, Serv Salud Maule, Dept Programas Personas, Talca, Chile
关键词
carcinoma in situ; prostate - specific antigen; prostatic neoplasms;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease. Aim: To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and methods: A probabilistic sample of 327 males aged 40 to 59 years old was studied. In all, a codified questionnaire was applied, a digital rectal examination was performed and a blood sample was drawn to measure prostate specific antigen. All digital rectal examinations were performed by the same observer. Patients with an abnormal rectal examination or prostate specific antigen were subjected to a prostatic biopsy under ultrasound guidance. Results: In 14 subjects, the digital rectal examination was considered abnormal and in seven, prostate specific antigen was over 4 ng/ml. All subjects with elevated prostate specific antigen had an abnormal rectal examination. In three of the 14 subjects, the biopsy showed a well differentiated adenocarcinoma. All three were aged over 50 years old. The resulting calculated prevalence of prostate cancer was 9.2 per 1,000 males (CI 4.2-14.1). Conclusions: the cost effectiveness of screening for early diagnosis of prostate cancer must be calculated, to decide its incorporation in preventive medical examinations (Rev Med Chile 2001; 129: 1305-10).
引用
收藏
页码:1305 / 1310
页数:6
相关论文
共 50 条
  • [31] Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies
    F L Bishop
    A Rea
    H Lewith
    Y K Chan
    J Saville
    P Prescott
    E von Elm
    G T Lewith
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 1 - 13
  • [32] Lead time of prostate cancer detected in population based screening for prostate cancer in Japan
    Ito, Kazuto
    Yamamoto, Takumi
    Miyakubo, Mai
    Takechi, Hiroyuki
    Ohi, Masaru
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2007, 178 (04) : 1258 - 1263
  • [33] Biomarkers for prostate cancer detection
    Parekh, Dipen J.
    Ankerst, Donna Pauler
    Troyer, Dean
    Srivastava, Sudhir
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2007, 178 (06) : 2252 - 2259
  • [34] Active surveillance of prostate cancer
    Bolenz, Christian
    Grimm, Marc-Oliver
    Heidenreich, Axel
    Kristiansen, Glen
    Schimmoeller, Lars
    Schmidt, Stefanie
    Schostak, Martin
    Hadaschik, Boris
    UROLOGIE, 2025,
  • [35] Prevalence of incidental prostate cancer in the general population: A study of healthy organ donors
    Yin, Ming
    Bastacky, Sheldon
    Chandran, Uma
    Becich, Michael J.
    Dhir, Rajiv
    JOURNAL OF UROLOGY, 2008, 179 (03) : 892 - 895
  • [36] Brachytherapy for prostate cancer in 2010
    Hakenberg, O. W.
    PANMINERVA MEDICA, 2010, 52 (03) : 183 - 188
  • [37] Evaluation of Vitronectin Expression in Prostate Cancer and the Clinical Significance of the Association of Vitronectin Expression with Prostate Specific Antigen in Detecting Prostate Cancer
    Niu, Yue
    Zhang, Ling
    Bi, Xing
    Yuan, Shuai
    Chen, Peng
    UROLOGY JOURNAL, 2016, 13 (01) : 2527 - 2532
  • [38] Endocrine treatment in prostate cancer
    Denis, LJ
    Griffiths, K
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 18 (01): : 52 - 74
  • [39] Prostate cancer prevention and finasteride
    D'Amico, Anthony V.
    Barry, Michael J.
    JOURNAL OF UROLOGY, 2006, 176 (05) : 2010 - 2012
  • [40] Evaluation of Prostate Specific Antigen Acceleration for Prostate Cancer Diagnosis
    Benecchi, Luigi
    Pieri, Anna Maria
    Pastizzaro, Carmelo Destro
    Potenzoni, Michele
    JOURNAL OF UROLOGY, 2011, 185 (03) : 821 - 826